Cibus, Inc. (CBUS)
CBUS Stock Price Chart
Explore Cibus, Inc. interactive price chart. Choose custom timeframes to analyze CBUS price movements and trends.
CBUS Company Profile
Discover essential business fundamentals and corporate details for Cibus, Inc. (CBUS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jul 2017
Employees
118.00
Website
https://www.cibus.comCEO
Peter Beetham
Description
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
CBUS Financial Timeline
Browse a chronological timeline of Cibus, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.31, while revenue estimate is $1.78m.
Earnings released on 14 May 2026
EPS came in at -$0.33 surpassing the estimated -$0.35 by +5.71%, while revenue for the quarter reached $1.68m , beating expectations by +4.67%.
Earnings released on 17 Mar 2026
EPS came in at -$0.42 surpassing the estimated -$0.43 by +2.33%, while revenue for the quarter reached $1.06m , missing expectations by -35.69%.
Earnings released on 13 Nov 2025
EPS came in at -$0.44 falling short of the estimated -$0.41 by -7.32%, while revenue for the quarter reached $615.00k , missing expectations by -62.58%.
Earnings released on 14 Aug 2025
EPS came in at -$0.61 surpassing the estimated -$0.69 by +11.59%, while revenue for the quarter reached $933.00k , missing expectations by -38.28%.
Earnings released on 8 May 2025
EPS came in at -$0.74 falling short of the estimated -$0.70 by -5.71%, while revenue for the quarter reached $1.03m , missing expectations by -10.28%.
Earnings released on 20 Mar 2025
EPS came in at -$0.87 falling short of the estimated -$0.68 by -27.94%, while revenue for the quarter reached $1.21m , beating expectations by +7.73%.
Earnings released on 7 Nov 2024
EPS came in at $0.06 surpassing the estimated -$0.90 by +106.67%, while revenue for the quarter reached $1.67m , missing expectations by -4.74%.
Earnings released on 8 Aug 2024
EPS came in at -$1.14 falling short of the estimated -$0.81 by -40.74%, while revenue for the quarter reached $838.00k , beating expectations by +90.45%.
Earnings released on 9 May 2024
EPS came in at -$1.12 falling short of the estimated -$1.01 by -10.89%, while revenue for the quarter reached $545.00k , beating expectations by +39.74%.
Earnings released on 21 Mar 2024
EPS came in at -$1.16 falling short of the estimated -$1.12 by -3.57%, while revenue for the quarter reached $1.10m , beating expectations by +190.26%.
Earnings released on 9 Nov 2023
EPS came in at -$1.59 falling short of the estimated -$1.18 by -34.75%, while revenue for the quarter reached $475.00k , beating expectations by +25.00%.
Earnings released on 9 Aug 2023
EPS came in at -$3.05 falling short of the estimated -$0.30 by -916.67%, while revenue for the quarter reached $197.00k , missing expectations by -95.72%.
Stock split effective on 1 Jun 2023
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 May 2023
EPS came in at -$1.09 surpassing the estimated -$3.00 by +63.67%, while revenue for the quarter reached $42.00k , missing expectations by -98.83%.
Stock split effective on 25 Apr 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 2 Mar 2023
EPS came in at -$0.06 surpassing the estimated -$5.50 by +98.91%, while revenue for the quarter reached $42.00k , missing expectations by -96.12%.
Earnings released on 3 Nov 2022
EPS came in at -$6.50 surpassing the estimated -$7.00 by +7.14%, while revenue for the quarter reached $42.00k , missing expectations by -88.00%.
Earnings released on 4 Aug 2022
EPS came in at -$2.50 surpassing the estimated -$6.83 by +63.41%, while revenue for the quarter reached $41.00k , missing expectations by -73.45%.
Earnings released on 31 Dec 2021
EPS came in at -$0.01 , while revenue for the quarter reached $1.94m .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 , while revenue for the quarter reached $7.76m .
CBUS Stock Performance
Access detailed CBUS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
